Akasaka International Law, Patent & Accounting Office.

Revision of the Foreign Exchange and Foreign Trade Act as of 2020

Oct 25, 2020

In light of the recent spread of a new type of coronavirus infection, from the perspective of maintaining the domestic manufacturing base for the medical industry, which is important for the lives and health of the people, and appropriately preventing a situation that could seriously affect Japan’s security, human life or health, we have decided to take the following measures
 Manufacturing of pharmaceuticals for infectious diseases (including pharmaceutical intermediates)
 Manufacture of highly controlled medical devices (including accessory and partial products)
 (hereinafter referred to as “core industries”) among the designated industries that require prior notification under the Foreign Exchange and Foreign Trade Act (Act No. 228 of 1949), and the related Public Notice of Amendments was published in the Official Gazette.


You are welcome to contact us via the Contact Form to discuss and for more information.